Healthcare

Name Desgination Name of the Company Company Description website
Mr. Len de Jong CEO Enraf-Nonius

Enraf-Nonius (1925) manufactures and supplies advanced high quality products for Rehabilitation and Physiotherapy. These products are distributed and supported by network of distributors in over 100 countries. The company has a large research and engiNoring department for the continuous development of new products and cooperates closely with universities and leading Rehabilitation institutes. Thanks to our growing business and increasing demand of space an ultramodern logistic centre is situated on the intersection of The Netherlands, Belgium and Germany, in Echt, Limburg. Enraf-Nonius stands for the highest quality, reliability and service, enabling health specialist to look after their patients and clients in the most effective and efficient way. EN-Projects, a division of Enraf-Nonius, specialises in Turn- Key integrated projects (Design- Build- Equip-Maintain-Train). EN-Projects realises large-scale global hospital projects and Rehabilitation Centres. With many years_ experience and proven reliability, EN-Projects is a valued partner for Ministries of Health or private hospitals. Integrated projects have been realised in Europe, Latin America, Asia and the Middle East. Reference list is available at: www.enprojects.com

www.enraf-nonius.nl
Mr. Leon Husson Country Coordinator India PUM Netherlands Senior Experts

PUM Netherlands senior experts offers knowledge and expertise in some 50 sectors of the economy. PUM was founded in 1978 by the confederation of Netherlands Industry and Employers (VNO/NCW) and the Dutch Ministry of Foreign Affairs and since then, we have been assisting over 40.000 businesses worldwide. We actively maintain a network of more than 150 representatives in 30 countries around the world, connecting directly with entrepreneurs, business support organisations and partners locally. We work with approximately 2000 senior experts - all volunteers - who share their knowledge on a one-on-one basis. Either through short-term and repetitive advisory missions at the work floor, seminars, through online coaching activities or business link visits to the Netherlands. Your company is a small or medium size enterprise, or you have an organisation supporting SME_s. You cannot afford commercial consultants, but you do want to solve your problems and grow your business. PUM can assist. Please visit www.pum.nl for more details.

www.pum.nl
Mr. Rob Noter CEO Careanimations

Careanimations is a Dutch medical company, specialized in explaining (public) health and medical subjects through animated videos, in such a way that even (very) low (health) literate people understand. Currently the Careanimations library consists of 7.500 videos. The videos are exclusively distributed to users by care institutions and/or health workers. For this, technical distribution solutions are available. Using this route, users appreciate the service and content, leading to more and better use. In The Netherlands, the Ministry of Health guarantees the reliability of the videos. Over 80? of hospitals, GP-practices and pharmacies offer Careanimations videos to their patients. In India, we offer two solutions: 1. In Public Health Video-packages for people in rural villages and urban slums about subjects such as sanitation, drinking water, (non-)communicable diseases, female hygiene, family planning, mother&child, substance abuse, domestic violence, etc. Meant for: NGO_s. Goal: empower health or social workers, such as ASHA_s, to make them more effective in inducing behavioral change among the target population to self-create betterment of living and health circumstances. At the horizon: improve the health and living conditions of 500 million people by 2030. 2. In Healthcare Video-packages for patients about diseases, medicines, interventions, labs, etc. This solution is comparable to the Dutch proposition, but adapted to Indian circumstances, languages and cultures. Meant for: private hospitals. Goal: improve hospital efficiencies and service as well as patient flow and outcomes. The software to store, select and distribute the videos have already been development in India. Now a separate company is being set up to offer the abovementioned solutions to the Indian people. All animated videos, meant for India, will be made in Mumbai. Careanimations is collaborating with NGO_s for the Public Health solution and with private hospitals for the Healthcare solution. During this Mission, Careanimations is looking for: Public Health initiative 1. Partnerships with CSR companies in a longterm collaboration together with partner-NGO_s to scale up the Public Health initiative to reach 500 million people by the year 2030. 2. Collaboration with State Governments to support and endorse the Public Health initiative with the objective to have it included in Ayshman Barath in due course. Healthcare solution 3. Collaboration with more hospital chains.

www.careanimations.com / www.zorganimaties.nl
Mr. Andre ten Brinke Managing Director Medpro Medical

MED pro medical is a Dutch manufacturer and supplier of medical disposables for urology, oncology and neurology. The products are mainly catheters, stents, dilators and electrodes. Our products are sold in over 40 countries across the globe. We are ISO 13485 certified, FDA registered and CE certified. Our facilities are located in the Dutch city of Veenendaal in close proximity to the Netherlands leading university hospitals and life science universities. We have close relation ships with Institutes like University medical center Utrecht, Erasmus medical center Rotterdam and the Dutch cancer institute. MED pro products and services: Catheters , stents, guidewires, dilators for urology Applicators and catheters for oncology/radiotherapy Electrodes for neuro surgery Product development With over 50 years of combined international experience in the medical industry, we are specialists in developing innovative new concepts, product designs and manufacturing processes for urology and oncology medical disposables . We have a large world wide sales network of distributors, enabling us to deploy new products quickly and efficiently. We also have partner ships with suppliers and OEM agreements with major system manufacturers.

www.medpromedical.nl
Mr. Rob Baak Marketing Director Medpro Medical

MEDpro Medical is a privately owned company, established in 2010. We are a fast-growing Dutch manufacturer and supplier of urology, oncology and radiotherapy disposable products, such as catheters, dilators and stents. Our facilities are located in Veenendaal, The Netherlands, in close proximity to some of Holland's leading academic hospitals; AMC Amsterdam, AMC Utrecht and the Radboud University hospital in Nijmegen. Our Medpro products have all been registered and are sold in more than 40 countries across the globe. We are ISO 13485 certified, FDA approved and we comply with the EU Directive 93/42/EEC regarding medical devices. Our Medpro team has more than 40 years of international experience in the medical industry. We are specialists in developing innovative new concepts, product designs and manufacturing techniques for medical disposables. We have a large worldwide sales network of distributors, enabling us to deploy new products quickly and efficiently. We also have partnerships with major suppliers and OEM agreements with system manufacturers.

https://www.medpromedical.nl/
Ms. Esther Van den Heuvel Programme manager Task Force Health Care

Task Force Health Care (TFHC) has been representing the Dutch Life Sciences & Health sector since 1996. Our various TFHC Platforms consist of partners from industry, knowledge institutes, NGO_s, healthcare providers and the government, all active in the Dutch Life Sciences & Health sector. These partners provide innovative and sustainable solutions to global (and local) healthcare challenges and are active all over the world. WHAT WE DO_ Stimulate cooperation and knowledge-sharing in order to combine forces within the Dutch healthcare sector, and; Present and position the Netherlands abroad in order to be involved in the global and local healthcare challenges. HOW WE DO IT_ TFHC organises all kinds of collective activities for Dutch organisations active in the Life Sciences & Health sector in order to stimulate cooperation and knowledge sharing. Through weekly activities inside- and outside The Netherlands like trade missions, holland pavilions, meetings and conferences; Through developing and sharing knowledge with the use of our website, social media and various publications; Through network facilitation and extensive relationship management.

Www.tfhc.nl
Mr. Nico Verdonschot Scientific Director University of Twente

The Technical Medical (TechMed) Centre is a leading Innovation Hub impacting healthcare by excellent Research, Innovation and Educational programs. It is equipped with state-of-the-art infrastructure, ranging from research labs, preclinical testbeds and simulated hospital environments. MISSION STATEMENT Improving healthcare by personalised technology Technology is a tool to enable high-quality healthcare. Not only for diagnosis and treatment, but also for improving the quality of life and to stimulate independent living. We strive to have a significant impact on society, both by scientific excellence as well as by linking fundamental research to clinical applications, from the nano to the global scale. Ultimately, we bring our technology to the clinic or to the home environment. For this purpose, it is imperative to have close working relations with clinical and industrial partners. In our mission to impact society, we stimulate entrepreneurship and enable (new) companies to grow within our regional Novel-T ecosystem, and collaborate with industry, hospitals, governments and insurance agencies on the development of new solutions for healthcare. Facts & figures about the University of Twente and healthcare We educate 1500 students in our TechMed BSc & TechMed MSc programmes We annually train 500 healthcare professionals by Life Long Learning We have 400 fte scientific staff 40% of the University of Twente_s funded scientific projects focus on Healthcare 50% of the University of Twente_s recent spin-off companies are dedicated to Healthcare

www.utwente.nl/techmed
Mr. Shekhar Yeskhadi Managing Director Careanimations

Zie aanmelding Rob Noter, Zorganimaties Careanimations is a Dutch medical company, specialized in explaining (public) health and medical subjects through animated videos, in such a way that even (very) low (health) literate people understand. Currently the Careanimations library consists of 7.500 videos. The videos are exclusively distributed to users by care institutions and/or health workers. For this, technical distribution solutions are available. Using this route, users appreciate the service and content, leading to more and better use. In The Netherlands, the Ministry of Health guarantees the reliability of the videos. Over 80% of hospitals, GP-practices and pharmacies offer Careanimations videos to their patients. In India, we offer two solutions: 1. In Public Health Video-packages for people in rural villages and urban slums about subjects such as sanitation, drinking water, (non-)communicable diseases, female hygiene, family planning, mother&child, substance abuse, domestic violence, etc. Meant for: NGO_s. Goal: empower health or social workers, such as ASHA_s, to make them more effective in inducing behavioral change among the target population to self-create betterment of living and health circumstances. At the horizon: improve the health and living conditions of 500 million people by 2030. 2. In Healthcare Video-packages for patients about diseases, medicines, interventions, labs, etc. This solution is comparable to the Dutch proposition, but adapted to Indian circumstances, languages and cultures. Meant for: private hospitals. Goal: improve hospital efficiencies and service as well as patient flow and outcomes. The software to store, select and distribute the videos have already been development in India. Now a separate company is being set up to offer the abovementioned solutions to the Indian people. All animated videos, meant for India, will be made in Mumbai. Careanimations is collaborating with NGO_s for the Public Health solution and with private hospitals for the Healthcare solution. During this Mission, Careanimations is looking for: Public Health initiative _ Partnerships with CSR companies in a longterm collaboration together with partner-NGO_s to scale up the Public Health initiative to reach 500 million people by the year 2030. _ Collaboration with State Governments to support and endorse the Public Health initiative with the objective to have it included in Ayshman Bharat in due course. Healthcare solution _ Collaboration with more hospital chains.

www.careanimations.com
Mr. Nuno Viegas CEO Mantis Therapeutics

As the facultative anaerobe Salmonella enterica serovar Typhimurium (S. Typhimurium) has the ability to colonize and replicate under both anoxia and oxygenated areas of tumours it seems to be able to colonize small metastatic lesions as well as larger tumours. Attenuated strains constructed with precise genome mutations have been assessed as an anti-solid cancer agent, and to date many clinical trials have been conducted using live attenuated Salmonella and have demonstrated safety of its use. We have developed a live attenuated Salmonella enterica serovar Typhimurium vector (BaCureTM) that has best-in-class efficacy against several cancer types. In pre-clinical models, our lead drug candidate elicits 100% colorectal cancer (CRC) growth inhibition, 100% renal cell carcinoma (RCC) growth inhibition and considerable life extension in fribrosarcoma. BaCure has built in safety features that contribute to its inability to proliferate in healthy tissue and increased safety in immunodeficient animals. In fact our lead vector is so safe that can be used to treat cancer in Rag 1-/- mice, that are deficient for B and T cells. Animals treated and cured with BaCure , survive the remaining of their live span tumor free and are able to eliminate any tumor challenges tested in months following treatment and cure. The multiple advantages of Mantis vector over competitor technologies, include long term efficacy, 100% survival, stimulation of powerful and specific anti-tumour immune response, oncolysis, potential usage as _troYesn horse_ to deliver active molecules to the tumour and is easy and inexpensive to produce. This means that BaCure has triple action; it can directly kill solid tumours, indirectly stimulate the immune system to detect and additionally kill the tumour and be used to deliver drugs in the tumour. Due to acquired knowledge and excellent pre-clinical results with our lead drug candidate, we are planning to initiate the Phase I human clinical trial with evaluation safety and clinical efficacy, in 2022. We are presently looking for Industrial or academic collaborators to further develop our pipeline in the future years.

https://www.mantispharma.com/
Mr. Peter Paul Platenburg BSc LiteVax

LiteVax is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel vaccine stimulants called adjuvants used to increase efficacy. Vaccines are the most cost-effective, medicinal products and half of the world-wide volume is manufactured in India. New vaccines against a wide range of infectious diseases are still Noded and to develop these joint effort of R&D organizations, manufacturers and regulatory authorities is required. India has the know-how, technology and infrastructructure to develop state-to-the-art products as wel as private parties with the ambition to develop and commercialize new products for domestic and foreign markets. This all makes India attractive for partnering our technology for a range of targets. Our strategy is to establish open and long-term partnerships with public and private vaccine R&D organizations. We follow an open business approach by supplying test material for internal evaluation, which expresses our confidence in product and partner. We were in India several times to meet R&D organizations and discuss possible collaborations. Next to B2B cooperations, we submitted collaborative grant applications, for example for the development of a new generation of flu vaccines with several EU and Indian parties.

www.litevax.com
Mr. Eras Draaijers Programme Manager Taskforce for Applied Research

In applied research, universities of applied sciences and public and private sector organisations work closely together aimed at improving professional practice and higher professional education. This enables the applied research performed by universities of applied sciences to make an important contribution to resolving social and economic issues. The Taskforce for Applied Research is committed to promoting more and even better applied research by universities of applied sciences. A key characteristic of this applied research is that it focuses on finding solutions to problems encountered by professionals in actual practice. Through the active collaboration between SME entrepreneurs and public sector professionals, the knowledge and findings acquired during the research ends up directly in professional practice. It also ends up in the curriculum of universities of applied sciences via research groups, lecturers and instructors. The Taskforce for Applied Research is part of the Netherlands Organisation for Scientific Research (NWO) and is financed by the Ministry of Education, Culture and Science. As a networking organisation, we work closely together with the Netherlands Association of Universities of Applied Sciences, the Confederation of Netherlands Industry and Employers (VNO-NCW), SME Netherlands, the Netherlands Organization for Applied Scientific Research (TNO) and the Chamber of Commerce.

http://www.regieorgaan-sia.nl/
Ms. Namita Krul-TaneYes CEO Meri Body

Making body literacy mobile, empowering and tangible! Meri Body, (meaning _my body_ in Hindi) is an e-health mobile app that forms a solution to a huge problem of ignorance around menstruation and the female cycle. We aim to empower and educate millions of semi-literate young women on female body literacy using simple animation videos and technology. Misconceptions unfortunately exist so a huge number of women think they are fertile during the menstruation days. The usage and knowledge will lead to improved healthcare, eradicating abortions (National estimate at 15,6 million in India in 2015) and tackling a world wide problem of ignorance. With the present demography of approximately 50% of its population under 25 years of age (65% under 35 years), it's highly essential to educate the youth on matters of menstruation, cycle tracking, reproduction, fertility, mother and child healthcare and anti-conception. The mission, vision and goals of Meri Body are aligned with the United Nations Sustainable Development Goals (SDG) 3, 4 and 5.

www.meribody.com
Mr. Freddy Weima Director General Nuffic

Nuffic is the Dutch organisation for internationalisation in education. From primary and secondary education to vocational and higher education and research. Together with our national and international partners, we strive to promote the development of our pupils and students, as well as the growth of teachers, professionals and organisations. In our globalising world, internationalisation is of growing importance for the entire education spectrum. Nuffic therefore wants all pupils and students to acquire international knowledge and skills from 2020. Capacity building in education and research is an important form of cooperation with developing countries. Our goal is to help these countries develop their own knowledge infrastructure in response to local and international Nods. Binding international talent and the value of internationalisation to the job market have become key themes. As a result, the significance of the corporate sector as a target group has increased. Alumni play a key role within this group. For these reasons, we will be intensifying our alumni activities in the years ahead.

www.nuffic.nl
Ms. Eveline van Engelen Teamlead Stakeholder Management Nuffic

Nuffic is the Dutch organisation for internationalisation in education. From primary and secondary education to vocational and higher education and research. Together with our national and international partners, we strive to promote the development of our pupils and students, as well as the growth of teachers, professionals and organisations. In our globalising world, internationalisation is of growing importance for the entire education spectrum. Nuffic therefore wants all pupils and students to acquire international knowledge and skills from 2020. Capacity building in education and research is an important form of cooperation with developing countries. Our goal is to help these countries develop their own knowledge infrastructure in response to local and international Nods. Binding international talent and the value of internationalisation to the job market have become key themes. As a result, the significance of the corporate sector as a target group has increased. Alumni play a key role within this group. For these reasons, we will be intensifying our alumni activities in the years ahead.

www.nuffic.nl
Mr. Henk Siebren de Jong Chief of International Markets, Executive Vice President, Member of the Executive Committee Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. As of Yesnuary 1, 2019, Philips_ reporting segments are composed as follows: Diagnosis & Treatment, which unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. Connected Care, which focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payerpatient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses (including the Home Respiratory Care business). Personal Health, which focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses.

https://www.philips.com/a-w/about/company/our-management/executive-committee/henk-de-jong.html
Mr. Luuk Hilgers Dr LiteVax

LiteVax BV is a Dutch biopharmaceutical SME with the mission to impact global health by developing and exploiting novel vaccine stimulants called adjuvants used to increase efficacy. Vaccines are the most cost-effective, medicinal products and half of the world-wide volume is manufactured in India. New vaccines against a wide range of infectious diseases are still Noded and to develop these joint effort of R&D organizations, manufacturers and regulatory authorities is required. India has the know-how, technology and infrastructructure to develop state-to-the-art products as wel as private parties with the ambition to develop and commercialize new products for domestic and foreign markets. This all makes India attractive for partnering our technology for a range of targets. Our strategy is to establish open and long-term partnerships with public and private vaccine R&D organizations. We follow an open business approach by supplying test material for internal evaluation, which expresses our confidence in product and partner. We were in India several times to meet R&D organizations and discuss possible collaborations. Next to B2B cooperations, we submitted collaborative grant applications, for example for the development of a new generation of flu vaccines with several EU and Indian parties.

www.litevax.com
Mr. Niels van Leeuwen Sr. advisor (inter)national R&D cooperation Life Sciences & Health Netherlands Enterprise Agency

Netherlands Enterprise Agency (RVO.nl) encourages entrepreneurs in innovative and international business. It helps with grants, finding business partners, research & innovation networks, know-how and compliance with laws and regulations. The aim is to improve opportunities for entrepreneurs and strengthen their position. Netherlands Enterprise Agency focuses on providing services to entrepreneurs. It aims to make it easier to do business using smart organisation and digital communication. The Agency works in The Netherlands and abroad with governments, knowledge centres, international organisations and countless other partners. Netherlands Enterprise Agency, and more specifically the Department of International Research & Innovation is the national contact point for all questions related to international R&D cooperation. Located in The Hague, the Netherlands Enterprise Agency has a team of project officers ready to help you set up your project and to assist you in applying for international, national, or regional funding. Netherlands Enterprise Agency supports the Dutch top sectors. One of the most prominent top sectors is the Life Sciences & Health sector.

www.rvo.nl
Mr. Ernst Soethout Managing Director Virtuvax

Virtuvax provides strategic advice, technology and expertise for the development of your vaccine. Our programs range from the development of single unit steps to full development starting from early concept until market authorization. We may generate your business plan or even design and build your new production facility. In addition, we provide off-the-shelf technology for the production of influenza vaccine. Altogether, our vaccine development programs enable the swift transition of your technology to a marketed vaccine. Virtuvax B.V. was founded in 2016 and is headed by Ernst Soethout. Having extensive experience in pharmaceutical research, vaccine development and business development, we strive to accelerate vaccine development and make the best possible vaccine technology available to our clients. For this, we make use of our extensive network in the vaccine industry, governments and the academic field. Virtuvax provides parties from various backgrounds with advice and expertise: _ Biotech companies, universities and knowledge institutes _ Vaccine manufacturers _ Biopharmaceutical industry _ Funding organizations such as VCs, governments and foundations _ Public health agencies Let's make technology work!

www.virtuvax.nl
Mr. Roderik Kraaijenhagen Dr. MD. Phd. Vital10

1.The healthcare system is complicated, opaque and difficult to navigate for even the healthiest among us. Whether we are trying to speak to a doctor, stick to a medication regime, analyze test results or monitor recovery progress, we are often reliant on a slow moving and uncommunicative network of clinics, hospitals and insurers. As health consumers, we expect more from our providers. We demand responsive, customized, clear and transparent support so that we can take on our personal health challenges with confidence. On demand healthcare is our solution. A doctor in your pocket! 2. We all want to live a healthier and happier life, whether that means recovering from a heart attack, fighting diabetes, reducing cholesterol or blood pressure, or simply working out more often. Unfortunately, managing our personal health issues can be confusing and frustrating. We have so many questions, but can_t ask a doctor without a costly appointment. We set goals but struggle to achieve them. We have become reliant on a broken system when all we want is the freedom to be healthy and happy. Getting healthy shouldn_t be hard. With Vital10, it won_t be. Vital10 inspires you to set goals and works with you to accomplish them. Every step of the way, our digital health coach will monitor your progress and ensure that your path to a healthy life is both efficient and effective. And if you Nod help along the way, Vital10 will connect you with an accredited expert (physician, physical therapist, trainer, or nutritionist) to conveniently answer any question you have, via your smartphone or computer. 3. Vital10 is not only a digital platform but it is a ecosystem for healthy living. Together with network partners outside the healthcare system we build a ecosystem for healthy living. Patients and clients can become member of vital10 and are provided dicount and extra services by partners in the eco-system. For example with supermarkets we focus on healthy products, we give access (via the platform) to all kinds of healthy recipes and by preparing your meal members earn V-points (health credits) by which they can earn extra discount and services. The eco system is provided by a 2 sided personal health app(lication) by which the preverences and Nods of the member are connected to suppliers.

www.vital10.nl
Ms. Sabine Pinedo Dr. MD. CEO Vital10

1.The healthcare system is complicated, opaque and difficult to navigate for even the healthiest among us. Whether we are trying to speak to a doctor, stick to a medication regime, analyze test results or monitor recovery progress, we are often reliant on a slow moving and uncommunicative network of clinics, hospitals and insurers. As health consumers, we expect more from our providers. We demand responsive, customized, clear and transparent support so that we can take on our personal health challenges with confidence. On demand healthcare is our solution. A doctor in your pocket! 2. We all want to live a healthier and happier life, whether that means recovering from a heart attack, fighting diabetes, reducing cholesterol or blood pressure, or simply working out more often. Unfortunately, managing our personal health issues can be confusing and frustrating. We have so many questions, but can_t ask a doctor without a costly appointment. We set goals but struggle to achieve them. We have become reliant on a broken system when all we want is the freedom to be healthy and happy. Getting healthy shouldn_t be hard. With Vital10, it won_t be. Vital10 inspires you to set goals and works with you to accomplish them. Every step of the way, our digital health coach will monitor your progress and ensure that your path to a healthy life is both efficient and effective. And if you Nod help along the way, Vital10 will connect you with an accredited expert (physician, physical therapist, trainer, or nutritionist) to conveniently answer any question you have, via your smartphone or computer. 3. Vital10 is not only a digital platform but it is a ecosystem for healthy living. Together with network partners outside the healthcare system we build a ecosystem for healthy living. Patients and clients can become member of vital10 and are provided dicount and extra services by partners in the eco-system. For example with supermarkets we focus on healthy products, we give access (via the platform) to all kinds of healthy recipes and by preparing your meal members earn V-points (health credits) by which they can earn extra discount and services. The eco system is provided by a 2 sided personal health app(lication) by which the preverences and Nods of the member are connected to suppliers.

www.vital10.nl
Mr. Ben Krose Lector Amsterdam University of Applied Sciences

Company name: Amsterdam University of Applied Science Profile: The Amsterdam University of Applied Science (AUAS) is the largest institute for higher professional education and cutting-edge research in the Netherlands, taking advantage of its privileged location in a city where 175 nationalities live. Scientific research at AUAS develops knowledge and applies it in professional practice and society. The Digital Life group focuses on information technology for healthy living and e-health applications. The group studies the use of sensors and advanced data analysis methods. It also researches the design, acceptance and effects of digital interventions. The group is embedded in the faculty of Digital Media and Creative Industries, thus involving advanced design methods and elements of gaming and play. Together with professors from the faculties of Health, Sports and Social Sciences, a program Urban Vitality has been developed, focusing on the creation of a vital and healthy Amsterdam. This program is carried out in close cooperation with the city of Amsterdam, health organizations and companies. Company: Amsterdam University of Applied Science, Adres: Digital Life Centre Theo Thijssen Huis Wibautstraat 2-4 1091 GM Amsterdam PO Box nummer: Postbus 1025 1000 BA Amsterdam website van uw bedrijf: http://www.hva.nl/ http://digitallifecentre.nl E: e-mailadres van de deelnemer: b.j.a.krose@hva.nl +31610963537

www.digitallife.nl
Mr. Yusuf Goedbloed CIO IndoDutch Healthy Village Foundation

Healthy Villages a tailor made global approach: Rural development and improving health care for rural population is a global challenge that may be addressed with an overarching approach: Healthy Villages. Access to health services depends on availability of health clinics and hospital, presence of doctors and medicines, but also the awareness and education to decide to seek health care at the right time as well as the (economic) possibility to get to a health post. A tailor made approach is developed with a modular programme for each unique location. The concept: Healthy Villages provide adequate availability and access to health care in rural areas. The concept bears community development at heart in order to guarantee health conditions in vital communities. Together with health care a clean environment, a healthy diet, security and presence of government institutions with provision of basic services such as education, clean water, energy and telecommunications, are considered crucial elements of well-being. Healthy Villages promotes self-determination and (economic) empowerment in order to achieve durable and adequate, personal well-being in communities and (rural) regions. By meeting the Nods of health care a local development process with the population, the government and public private (international) projects is ignited over a number of years.

www.healthyvillages.in
Ms. Carmen van Vilsteren IR. Health-Holland

About Health~Holland (Top Sector Life Sciences & Health) The Dutch Life Sciences & Health (LSH) sector is one of nine _top sectors_ in the Netherlands. The top sectors are designated by the Dutch Ministry of Economic Affairs and are selected on their ability to contribute substantially to global societal challenges. Health~Holland is the Top Sector LSH's communication channel. The Top Sector LSH entails a broad scope of disciplines, from pharmaceuticals to medtech, from healthcare infrastructure to vaccination. In order to realise its mission _ vital functioning citizens in a healthy economy - the top sector builds on the strengths of the Dutch Life Sciences & Health sector to address the biggest societal challenges in prevention, cure and care: improving the quality of life (vitality) while restraining the costs of healthcare The Top Sector LSH initiates and stimulates multidisciplinary public-private partnership (PPP) to valorise innovation. By attracting financial means, sharing best practices and the univocal Health~Holland sector communication, the top sector boosts a productive infrastructure.

www.health-holland.com
Mr. Shaji Krishnan Senior Scientist TNO

TNO is an independent research and technology company with over 3900 highly qualified professionals which makes it one of the largest in Europe. TNO makes scientific research accessible and applicable for businesses and government. As the national institute for applied science TNO covers all technologies like IoT, blockchain, AI and 5G. Core competences that enable smart city developments and integrated services. TNO_s main themes are: smart mobility, circular waste & energy and full water cycle management are targets as well as eHealth and mHealth. It also focusses on lifestyle and Healthcare with AI as its cornerstone . The Big Data Value Center (BDVC) is a unique open innovation platform for shared value creation with Big Data. As independent foundation the BDVC offers a large network that contributes knowledge, insights and business cases. It hosts the Dutch national Linked Data community and offers access to operational field labs like the Amsterdam ArenA Stadium and exports smart stadium solutions.

www.tno.nl
Ms. Maria van der Heijden Managing Director MVO Nederland MVO Nederland

MVO Nederland represents Europe_s largest movement of entrepreneurs and businesses towards the new economy. With our network of over 2000 companies we strive for an economy that is climate neutral, circular, inclusive and with fair supply chains. In partnerships with Dutch and international companies we improve existing value chains, and we support companies with sustainable innovations and business models to enter international markets. At the level of Dutch and European government we lobby for ambitious CSR policies supporting a sustainable economy. Our goal has been achieved when at least 20 percent of the national GDP is obtained by sustainable business. We aim to reach this tipping point by 2025. The Indo-Dutch Sustainability Forum _INDUS_ is an initiative of the Embassy of the Kingdom of the Netherlands in India and MVO Nederland that aims to make all trade and investments between India and the Netherlands sustainable. In this context, Indian and Dutch businesses, knowledge partners and governmental institutions agreed in a Memorandum of Understanding to assess possibilities of cooperation. As a follow-up, a variety of players, consisting of supply players, production companies, technical solution providers, buyers, signed a Partnership Agreement in April 2019, with concrete actions. The consortium includes Paperwise, Bio4Pack, Ecor, Feed the Seed, Mars, and LT Foods, Haryana Agricultural University, and GVK Society. The following Indian companies and organisations are partners: Haryana Agricultural University, Indian Packaging Institute, Central Pulp & Paper Research Institute, Farm2Energy, GVK Society, LT Foods and FarmSolutions.  

https://www.mvonederland.nl/
Mr. Peyoush Datta Director IPA Projects & Services

IPA Projects & Services has been a one stop shop for companies that want to expand into Europe. Being active for the past 20 years has enabled to assist any company that is active in Agro-Food, High Tech and IT and Healthcare. IPA is not your average project management company. We have in house talent in various fields, making us very efficient in assisting a large variety of companies. We are able to assist in the following phases: - Market Research - Business Development - Risk Assessment - Technology Procurement - Certifications and Govermental Approvals (Compliance) - Physical setup of a business (factory) Our most recent projects have been for LT Foods and Bayer. Setting up a rice milling plant from scratch in Rotterdam and automating the production of a nuclear based medicine. In Parallel we are actively involved with Tech Startups and help them expand into India. We are hoping to do the same for Indian companies, but then into Europe.

www.ipa-ps.nl
Ms. Petra van Baak (senior) policy adviser Life Sciences & health Ministry Economic Affairs & Climate policy

Ik zal meereizen als ondersteuning/ begeleiding van de missieleider van het Health track cq boegbeeld LSH. (uit: actieprogramma Nederland heeft een sterke positie op het gebied van Life Sciences & Health (LSH) in Europa. Ons land heeft één van de meest geconcentreerde LSH clusters ter wereld. Binnen een straal van 190 km zijn er 2900 innovatieve R&D life sciences bedrijven, inclusief 420 biofarmaceutische bedrijven. In universitaire ziekenhuizen, universiteiten en kennisinstellingen is er uitstekende expertise op gebieden zoals kankeronderzoek, hart- en vaatziekten, infectieziekten en neurodegeneratieve aandoeningen. EZK-actieprogramma _Nieuwe kansen voor Topsector Life Sciences & Health_ De komst van het Europees GeNosmiddelen Agentschap (EMA) naar Nederland biedt kansen om meer bedrijvigheid aan te trekken en de LSH sector te ontwikkelen tot dé Life Sciences & Health hub in Europa. Meer bedrijvigheid komt ten goede van zowel de Nederlandse patiënt als de economie. Het kabinet erkent ook de maatschappelijke en economische kansen die de komst van de EMA biedt. De ministeries van Economische Zaken en Klimaat en VWS ontwikkelen daarom gezamenlijk een nationaal actieprogramma _Nieuwe kansen voor Topsector Life Sciences & . Van belang is dat Nederland zich internationaal met één samenhangende propositie profileert. en Om deze en andere ontwikkelingen in gang te zetten wordt het Nationaal actieprogramma «Nieuwe kansen voor topsector Life Sciences & Health» ontwikkeld en uitgevoerd in nauwe samenwerking met Topsector LSH en betrokken departementen. Een belangrijk onderdeel van het Nationaal actieprogramma zal de versterking van de strategische acquisitie worden, gericht op bedrijven die het LSH-ecosysteem kunnen versterken.

x
Mr. Gaurav Gupta Regional Ambassador i-team Global

i-team Global focuses on the development & design of high-end cleaning machines, products and utilities. Ranging from scrubber dryers, vacuum cleaners, gum removers, lighting solutions, microfibre pads and all-in-one cleaning islands. Our goal is to simplify the entire cleaning process and to bring back the fun in cleaning.Our flagship innovation is the i-mop XL scrubber dryer, which has revolutionized the cleaning industry by changing the process of cleaning. Since the introduction of this innovation, we have expanded our entire range with over 20 products. i-team Global is considered a worldwide key innovator, spanning more than 60 countries and ever expanding.We are not limited to only innovating machines as most other companies do. We innovate in processes and cleaning related mediums e.g. water, chemicals etc. to achieve real sustainability in the cleaning industry. . I-team Global redefined the standards and expectations of cleaning. We redefined the cleaning space as 4D, including the dimensions of floors, furniture, walls & ceilings and the air within a facility. It is only by addressing these interrelated dimensions that a facility can be made optimally clean.

www.i-teamglobal.com
Mr. Bart Haagmans dr. Erasmus University Medical Center

Netherlands Centre for One Health (NCOH) aims for an integrated One Health approach to tackle the global risk of infectious diseases. NCOH commits to create durable solutions for this major challenge by bundling world-leading academic top research in the Netherlands in the area of One Health. To formulate an answer to these grand challenges and develop global, integrated solutions, it is important to bundle knowledge and expertise in the field of One Health research. Therefore, the Netherlands Centre for One Health (NCOH) was initiated. NCOH is an open virtual science-driven network that bundles world-leading academic research groups, across different institutions in the Netherlands, that are active in various complementary fields of One Health research. NCOH aims to perform fundamental, translational, and applied scientific research that integrates human, veterinary, and environmental elements and considerations. It focuses on studying the interactions and connections between human, veterinary, wildlife, and environmental health in pursuit of durable solutions to grand societal challenges requiring a One Health approach. The NCOH aspires to function as the national coordinating platform for One Health research, strengthen and consolidate the One Health knowledge and research basis in the Netherlands, and provide a trusted and excellent launching platform for public-private partnerships in the international One Health research field. Initiated by Utrecht University, University Medical Center Utrecht and Wageningen University & Research. Joined by Erasmus Medical Center Rotterdam, Academic Medical Center Amsterdam, Leiden University and Leiden University Medical Center. NCOH closely collaborates with the RIVM and is open for participation by Dutch Universities, University Medical Centers, NWO and KNAW institutes, and TNO and Wageningen Research institutes. NCOH has one common Strategic Research Agenda with four complementary Strategic Research Themes. Infectious diseases form a world-wide threat to human and animal health. Prevention and the control of infectious diseases outbreaks is an important societal challenge. Another grand challenge is posed by antibiotic resistance. Prevention of resistance and development of novel therapeutics and treatment strategies is of world-wide importance. As the causes and possible solutions also include components of healthy farming and healthy wildlife and ecosystems, a One Health approach is required to solve these major societal challenges.

https://ncoh.nl/
Ms. Anupam Nayak Founder & CEO Eindhoven Medical Robotics

We design and manufacture high precision surgical robots. These image guided systems cater to skull base surgery, ophthalmology, steerable instruments for imaging, biopsies and ablations; and instruments for deep brain procedures. We aim to be the world leader in surgical robotics and a 1000+ team in the few coming years. Typically it takes 10-12 years to train surgeons for precision surgery and quite often they retire early as tremors set in due to age, hampering them from performing their work. We give surgeons mechanical hands to start earlier and go on forever. We focus on small sized, affordable, safe and reliable precision systems. The current robotics systems cost 2.5m USD + extra costs for instruments and services per surgery. We aim to bring the cost down under 1m without sacrificing performance . The first product will be systems to assist bone removal for skull base surgery. This is for removal of inner ear tumors and placements of cochlear implants to restore hearing loss. Currently 350 million people in the world are in Nod of such surgeries out of which 32 million are children. Only 1 in 10 have access to expert surgeons. We recently won the NL-India GlobalStars grant in which we will develop spine surgical systems along with RadboudUMC, CMC Vellore and IIT Madras. In the grant project we will expand on the bone platform for skull base surgery to the spine to address the Nod for affordable precision procedures for patients worlwide. We are currently busy with feasibility studies for steerable catheters for heart tissue ablations. In India we are actively working with surgeons in Mumbai, Bangalore, Chennai and Vellore. We look forward to setting up world class training programs for educating surgeons in robotic surgery and launching training systems and patient surgical systems in India.

http://www.emrobotics.com/
Mr. Peter van Londen COO WorldEmp

WorldEmp facilitates Indian international talents with a Bachelor_s or Master_s degree for companies in the Netherlands and Europe. _ Remote workers. The WorldEmp concept gives European/Dutch organizations the opportunity to add new employees to their European/Dutch teams. Employees which are difficult to find in their own region. Organizations can, by applying the WorldEmp concept, continue their business and growth, without the lack of personnel. The dedicated employees will work remotely from a WorldEmp office, within the team of the WorldEmp customers. _ Managed departments/teams. Some of the WorldEmp customers have chosen to set-up teams in India, which work as a separate department, managed technologically by a project manager. WorldEmp facilitates HR and recruitment services, as well as offices and payrolling. _ Set-up of Indian branches of Dutch/European companies. A Dutch/European organization, which wants to start an office in India, can use the WorldEmp concept. Low risk and low cost. WorldEmp will recruit, hire and employ the dedicated employees, so that business operations can start and grow, while the other activities for setting up a daughter company in India can be completed. As soon as the new branch office is opened, the employees can be transferred, and the company is up and running in India, cost-efficient and profitable from day one. _ Recruitment for the Indian branches of Dutch and European companies already present in India. WorldEmp supplies high quality recruitment for European organization, which Nod the best available and best fitting employees. _ Relocation of employees to the Netherlands/Europe. WorldEmp can offer the recruitment service in India for companies who Nod the employees locally in the Netherlands/Europe. WorldEmp will search and recruit possible employees for relocation and prepare relocation. The employees, who are facilitated to the WorldEmp customers, work from a WorldEmp office in India. The employees are part of the local Dutch team of the customer. They communicate with the help of a video connection and are directly managed by the customer. The client therefore still has total control over the quality and delivery time of the work as well as the knowledge, which is not the case with outsourcing. WorldEmp provides the HR management of the colleague in India including payrolling, well-being of the employees in the office, cooperation, training etc.

www.worldemp.com
Mr. Gideon Kersten Chief Scientific Officer Intravacc

Intravacc, the Institute for Translational Vaccinology, is an experienced R&D organization with a proven track record in vaccinology of over 100 years. Intravacc originates from the Institute of Public Health in the Netherlands in Bilthoven. We have a wide range of expertise to independently develop vaccines from lead concept to clinical phase I/II studies as well as our own product pipeline and patents. Our ambition is to bridge the translational gap between vaccine lead finding and clinical development. Technology, know-how and products are transferred to partners. We have our own vaccine development program and provide fee for service activities. Intravacc also engages in co-development with vaccine manufacturers, small biotech as well as research institutes. Improving global health is a central theme which materializes in collaboration with vaccine manufacturers all over the world, support from the World Health Organisation, the Bill and Melinda Gates foundation and others. Our platform technologies allow efficient vaccine development, especially in the area of Vero-cell based viral vaccines, bacterial outer membrane vesicles and conjugate vaccines. This has resulted in a solid knowledge base (120+ publications in the last 5 years) and vaccines brought to the clinic or licensed. The latter include H. influenzae type B conjugate vaccine (licensed) and Sabin based inactivated polio vaccine (phase 3).

www.intravacc.nl
Mr. Louis Hendriks Managing Director Global Value Web

Global Value Web (GVW) has an active presence in India. Providing services to the global lifesciences industry. In the digital journey of this industry an enormous amount of specialised data is consolidated, harmonised, curated and maintained by lifesciences professionals. GVW processes a series of laboratory enabling services, ensuring that data is correct, accurate and timely available for the Research, Development and Operation functions of leading lifescience companies. These services contribute to a higher level of quality across the value chain. By working with GVW Indian life science companies can boost their data integrity, and thus reliability of their products. Services include, but not limited too; - material specifications creation and maintenance (material masters, doc management and Lims) - lab methods creation and maintenance - Reagents and Equipment data maintenance - sample plans - environmental monitoring - analysis - technical writing - pharmacopeia monitoring - impact assessments - change control services - document writing - stability studies - t0 time points - Lab Systems access control - Lab training management - Lab training documentation - Sample Logistics Management - Oral solid dissolution analytics - quality control analytics - supply chain reliability analytics - global planning analytics - lab assessment (focus on DI) - Development enabling services - supplier risk assessment reports - Real World Evidence / OHDSI - Clinical trial services (Emerging) Technologies; - Resale Lab Systems (LIMS, LES, ELN, SDMS) - Product Lifecycle Management (PLM) - Digital Lab Expert - Block Chain for the Lab - Connecting the Lab - Manufacturing Analytics (EMI)

Www.global-value-Web.com
Mr. Wim van der Poel Professor, Research Leader Global One Health Wageningen University & Research

Wageningen Bioveterinary Research contributes to the prevention, eradication and control of animal infectious diseases through research, diagnostics and consultancy. By doing so, we help to guarantee international trade and to preserve the international top position of the Dutch livestock industry. Furthermore, we offer high quality routine analyses and provide innovative solutions to veterinary and biomedical research questions. The Netherlands Centre for One Health (NCOH) aims for an integrated One Health approach to tackle the global risk of infectious diseases. www.wur.nl; www.ncoh.nl . Within the European program of One Health we develop dedicated Joint Research Projects (JRPs) and Joint Integrative Projects (JIPs), and establish education and training in the fields of Foodborne Zoonoses (FBZ), Antimicrobial Resistance (AMR) and Emerging Threats (ET) , www.onehealthejp.eu In 2018, we established an international Global One Health network with three other top-ranked agricultural universities: University of California in Davis, USA, Nanjing Agricultural University in China and Massey University in New Zealand. This network enables PhD exchanges, and we are currently working on a Global One Health cooperative research programme for this network. https://onehealthejp.eu/places/wbvr/

www. wur.nl
Mr. Yesn Nouwen Coordinator Research & Global Health Education Erasmus University Medical Center

Erasmus University Medical Center, known as Erasmus MC is the result of the merger between the Faculty of Medicine-Erasmus University Rotterdam, and the three university hospitals (a general, pediatric and cancer hospital). Faculty and hospitals are all integrated into one campus and lead by one executive board. Erasmus MC is committed to a healthy population and excellence in healthcare through research and education (www.erasmusmc.nl). Research&Innovation: Erasmus MC has been consistently ranked in the world_s top 25 for clinical medicine (USNews Clinical Medicine 2015: no19) and it_s research publications are cited 1.75 times the world average. The overall research aim of Erasmus MC is to translate bench discoveries to bedside applications. Education&Training: Erasmus MC is also the largest medical school in the Netherlands, with ~2,500 medical students and ~250 PhD graduations/year. It has the most research-focused medical education in the Netherlands and 25-33% of medical students finishes as MD-PhD, being both clinical doctor and scientist. Erasmus MC offers BSc, MSc and PhD programs to train the next generation of medical practitioners and researchers. Patient care: Erasmus MC is building a new ~1,000 single patient bedrooms hospital (finished in 2017) to accelerate its medical innovation and ability to treat patients with the newest and best materials and treatments. Economic impact: A study showed that its impact on the Dutch economy was such that every euro invested in Erasmus MC resulted in _ 4,58 and every job at Erasmus MC resulted in a total of 4.12 jobs elsewhere in the Netherlands.

www.erasmusmc.nl
Mr. Koert Stittelaar General Manager Xplore Viroclinics Xplore

Viroclinics routinely performs a range of pre-clinical and clinical diagnostic services, including but not limited to; high throughput serology-, virology- and molecular assays, phenotyping, and genotyping in both translational studies and phase I-IV clinical studies. Moreover, in order to achieve sponsor_s development goals most efficiently, the company offers the option of designing customized models and protocols. As a final point, Viroclinics has an annual budget and supports an active in-house research and development program. Both preclinical and clinical diagnostic departments are supported by the assay development department for designing customized solutions. Viroclinics Xplore, a new business unit of Viroclinics Biosciences B.V., focuses on early stage, preclinical contract research services. Throughout the years, Viroclinics invested heavily in its preclinical facilities to cope with the increasing demand in the market. This resulted in the foundation of a 1600 m2 preclinical facility. After establishing a solid portfolio of viral targets such as influenza, Viroclinics became a recognized partner for polio eradication. Preclinical contract research services are at the core of our company. With Viroclinics Xplore we are able to better serve our customer´s specialized Nods, without losing focus on our integrated service platform, designed around all phases of anti-viral drug and vaccine development.

www.viroclinics.com
Mr. Remko van Leeuwen Director of Acquisitions Amsterdam Institute for Global Health and Development

The Amsterdam Institute for Global Health and Development (AIGHD) is an international research and education institute that works to develop sustainable solutions to major health problems. AIGHD was initiated as a partnership between the Amsterdam UMC, the University of Amsterdam (UvA) and the Vrije Universiteit Amsterdam (VU). Today, it is a dynamic research and education institute that thrives on intense collaboration among experts from multiple disciplines including biomedicine, economics and social and behavioral sciences. With its interdisciplinary and translational approach, AIGHD addresses the most critical medical, social, economic and political challenges in global health and development that cut across national and political borders. We are participating in the mission, as we would like to connect with parties in India for collaborative work in 3 of our priority areas: - The global fight against the rise antimicrobial resistance - Development low-cost vaccines for poverty related diseases - Reversing the epidemic of diabetes mellitus We aim to link up with partners that can help us: - Getting a better understanding of the drivers of the listed problems - Creating a stronger innovation climate for innovative strategies and products - Promoting a interdisciplinary and cross-sectional approach towards development of new technology - Ensure equitable, faster & better access to all those is Nod - Focus on prevention where possible - which is always better than cure

www.aighd.org
Mr. Frans van den Boom Executive Director Europe Human Vaccines Project Europe

The immune system is the human body_s primary mechanism for staying healthy. Decoding it should be central to our efforts to understand and fight disease, whether non-communicable diseases such as cancer, diabetes, and Alzheimer_s, or infectious ones such as tuberculosis, malaria, and Ebola. HVP is harnessing the power of the human immune system with the enormous potential of machine learning and artificial intelligence, to decipher the key principles guiding human immunity across diseases. HVP's scientific plan focuses on: 1. Understanding the rules and components of immunity 2. Creating AI-driven models of immunity In the first 3 years of the Project, we have already: 1. Open sourced the first sequencing of the human immune system. 2. Used machine learning to predict who will and will not respond to vaccination. 3. Established one of the world_s leading scientific consortium across industry, government, and academia. In the next five years, we aim to accomplish the following: 1. Finish the initial genetic sequencing of the human immune system. 2. Determine the initial rules by which the immune system fights disease. 3. Develop the first AI models of the human immune system

www.humanvaccinesproject.org
Mr. Laurens Van Hoorn Head of International & HealthInc Amsterdam Institute for Global Health and Development

We are participating in the mission, as we would like to connect with parties in India for collaborative work in 3 of our priority areas: - The global fight against the rise antimicrobial resistance - Development low-cost vaccines for poverty related diseases - Reversing the epidemic of diabetes mellitus We aim to link up with partners that can help us: - Getting a better understanding of the drivers of the listed problems - Creating a stronger innovation climate for innovative strategies and products - Promoting a interdisciplinary and cross-sectional approach towards development of new technology - Ensure equitable, faster & better access to all those is Nod - Focus on prevention where possible - which is always better than cure

www.ahti.nl
Mr. Yescco Vroegop Medical Director Faceland / Worldeye

Faceland is established in 2013 and does have 12 locations in the Netherlands, 1 in Germany and 1 in Switzerland. Our vision is to make aesthetic medicine and plastic surgery acceptable an accessible to everyone. Worldeye Amsterdam is established in 2017 and belongs to an international leading group of eye hospitals. We are offering all kind of eye treatments, and are especially specialised in refractive surgery: helping people seeing again without glasses or lenses by an implant lens or laser treatment. Both companies working together in bringing healthcare to the next level, helping people to stay mental and physical healthier during their lives. We believe stem cell treatments are the next step in health care. Therefore we are planning to open before the end of the year a stem cell clinic in Zürich Switzerland. We are looking for partners with experience in stem cell treatments, in doing scientific research with us, and delivering high quality of mesenchymal T- and B-stem cells. We are looking forward to a cooperation!

www.faceland.nl / www.worldeye.nl/engels
Mr. Servaas Morre Professor, Founder, advisor Microbe&Lab

I represent both the SMEs and my Professorships in Maastricht-NL and Allahabad-India. The central theme in both settings is Female Reproductive Health (FRH). Improvement of FRH is achieved by developing new diagnostic tools and treatments via research and epidemiological studies (India, Tanzania, South-Africa). We work on 4 levels Level 1. Sexually Transmitted Infections: development of state of the art STI tests for both Laboratories/Hospitals and for Direct to Consumer testing. CE-IVD approved assays available (CT NG TV and MG) Level 2: Infertility. When you are too late with treatment of for example Chlamydia trachomatis women get infertile. We develop a host genetic based assay linked to a online platform for big data analyses to aid in better diagnosis of tubal factor infertility (CE-IVD Ready 7/2020) Level 3: IVF failure: We have developed a microbiome based prediction rule (linked to an online analyses tool for big data interpretation) which can predict failure of IVF with 95% based on your vaginal microbiome (CE-IVD). Unique assay which we want to promote in India since Female Infertiliy is among the highest worldwide in India Level 4: Vaginal microbiome adaptation. Women who have a microbiome which results in IVF failure should be able to modify their microbiome via pre/probiotics & antibiotics.

www.tubascan.eu & www.inbiome.com
Mr. Yesn van den Berg Member of Supervisory Board Joep Lange Institute

Achmea is the leading health care insurance company in the Netherlands and the largest European health care insurer. It is widely diversified into health services for corporate customers as well as individual customers. Achmea serves more than 10 million customers. It has gained recognition for digital service and customer engagement concepts. As a health care insurer it actively helps customers find the best and most suitable care. Achmea is actively developing new health care services for chronic diseases aimed at improving quality of life and developing affordable care concepts which also empower patients themselves. The use of mobile technology and data driven care concepts is a new chapter in health care and for health care insurance. Diabetes is one of the most prevalent chronic diseases benefiting from the new opportunities in data and digital. Helping patients regain and maintain vitality is an important part of insuring health in addition to supplying health care to deal with disease. Achmea also has an extensive corporate social responsibility program and actively contributes to development of health care systems in society to help it develop in a sustainable manner.

achmea.com
Mr. Micha van Lin Director Task Force Health Care

Improving healthcare together by connecting the right people. Task Force Health Care (TFHC) has been representing and supporting the Dutch Life Sciences & Health sector since 1996. Our various TFHC Platforms consist of partners from industry, knowledge institutes, NGO_s, healthcare providers and the government, all active in the Dutch Life Sciences & Health sector. These partners provide innovative and sustainable solutions to global (and local) healthcare challenges and are active all over the world. OUR MISSION... To improve healthcare and wellbeing internationally in a sustainable and demand-driven manner with the use of Dutch expertise. WHAT WE DO... * Stimulate cooperation and knowledge-sharing in order to combine forces within the Dutch healthcare sector, and; * Present and position the Netherlands abroad in order to be involved in the global and local healthcare challenges. TFHC has been active in India for a number of years and has a ongoing MoU with NatHealth. We stimulate cooperation and (public-private) consortia between India and The Netherlands.

www.tfhc.nl
Mr. Maarten Steinbuch CEO Eindhoven Medical Robotics

Eindhoven Medical Robotics develops high precision surgical robotics. We aim to be a 1000+ team in the next 10 years and a world leader in surgical robotics. Our robots improve the capabilities of the hands of surgeons, by utilizing high precision robotics and mechatronics, including image processing and navigation. We work in close collaboration with universities both in NL, USA as well as in India, such as TU/e, Radboudumc, MIT Boston, IIT Madras, etc. Also with engiNoring partners, suppliers and hospitals worldwide. The surgeons supporting us are highly respected in their fields and enjoy the surgical challenges they solve through engiNoring with us. We work as a multi-disciplinary project team comprising of system architects, mechanical, electrical and software engiNors. We have diverse projects in different phases: early research, rapid prototyping for demos, pre-clinical prototypes at hospitals and regulatory compliant developments for human trials. We have received first customer orders for our robot system. Team: We have 10 FTE employees, and growing towards 15 FTE end 2019 Location: We have moved into our new office at the TU/e science park, with 400m2 of lab and office space. see also the text of anupam nayak

www.emrobotics.com
Mr. Bart Geerts CEO Healthplus.ai

Healthplus.ai is an artificial-intelligence startup from Amsterdam that re-uses existing data to provide health care professionals and patients with insights that lead to proactive treatment of health conditions. Our first tool (called PERISCOPE) focuses on hospital infections; As 60-80M of 320M surgery patient globally per year get an infection after their procedure, we look to enable personalized and proactive treatment of the patient to improve outcome, patient and HCP experience, and reduce cost. With leading hospitals in Europe and the US, and major EHR vendors, we are bringing an EHR-plugin (electronic health record) tool to the market that predicts post-surgery infections with 90+% accuracy 5 days prior to the current average diagnosis reusing data in our cloud-based ML algorithm . We are looking to pilot PERISCOPE in post-surgery populations in public and private hospitals in India to aid in improving quality, experience and cost-efficiency of care. We are also on the lookout for Indian R&D partners (government, hospital and/or commercial) to put AI to work and deliver better healthcare (products) with the right partners.

www.healthplus.ai
Mr. Cornelis Boersma Board Member NADP

The Netherlands is home to a vibrant, concentrated Life Sciences Health cluster with more than 2200 life science and MedTech companies and research organisations, all within a 120-mile radius. As such it is the most geographically concentrated region in the world when it comes to creating economic and social value in Life Sciences and Health. The excellent medical research infrastructure is strongly focused on translational research in different medical fields including infection and immunology of animal and man. Worldwide, the Netherlands ranks 6th and 8th in life sciences and health citations and patents, respectively. Within the Netherlands, 10 universities, 8 university medical centers and 3 technological universities are active in R&D of antimicrobial solutions. In nationwide public-private R&D programmes these research organizations cooperate in different niches such as identification and lead optimization of new antibiotics and alternative therapies (NACTAR programme), bacterial vaccine technology development (Bac Vactory programme), and point-of-care diagnostics (ZonMW antimicrobial resistance programme). In addition, active participation of many of these institutes is seen in European-funded R&D programmes. In particular, a prominent role is being played by the Netherlands in the IMI-funded program NewDrugs4BadBugs, in which amongst others a European clinical infrastructure for anti-infectives efficacy testing is being established (COMBACTE project). Also a number of H2020 programmes are running focused on antibiotic development and production (SynPeptide; Rafts4Biotech). The Netherlands Antibiotic Development Platform (NADP) facilitates the collaboration between public and private organisations, to enhance the development of new antibiotics and alternative therapies for infectious diseases in humans and animals. NADP identifies relevant research groups, institutes and companies involved in chemical, biological, and/or biomedical antibiotic research to forge collaborations through targeted connections and will organise regular meetings with interested parties. NADP brings together Dutch academic institutions, medical centers, and private organizations working on R&D of antibiotics and alternative spanning the entire spectrum of basic research to clinical Phase IV studies. The NADP aims to collaborate with international initiatives to stimulate active contribution of antimicrobial research and drug development in The Netherlands. Reflective of the expertise and research excellence in the Netherlands, three focus areas are identified within the NADP that aim to decrease our dependence on last resort antibiotics: 1. New antibiotic molecules; 2. New alternative therapeutics; 3. Clinical infrastructure. The focus areas enable NADP in its support of collaborations between public and private organisations aimed at finding and accelerating the development of new antibiotics and alternative therapies. See for more information nadp.nl

www.nadp.nl
Mr. Akbal Mohamed Directeur Amrit Consultancy

Amrit Consultancy develops web applications and mobile apps. For the diabetes sector, Amrit has developed an application for the D-Support Foundation and the Diabetes Fund to link babysitters of families with children with diabetes and to monitor the process of babysitting a child with diabetes. For the Halotherapy Foundation, Amrit is developing a project to monitor clients of Salt Rooms who are connected to the Foundation in their visits to a salt room. Halotherapy is a treatment in a specially developed salt chamber, where the natural microclimate of salt caves is simulated. The client inhales a fine salt spray. Due to the small particle size (less than 1 micron), this natural salt even ends up in the lower respiratory tract and lung vesicles. Amrit has previously developed an application for Haga Hospital to administer heart surgery. The quality of cardiac surgery is determined based on the data from that application. We work togethet with Stabij and Palime.

www.amritapplications.com
Mr. Leonard Wee Senior research scientist Maastricht University Medical Centre+

Maastro is a nationally and internationally renowned radiotherapy center that explicitly seeks to make the connection between optimal patient care, education and effective scientific research. We want to offer patients a treatment aimed at the greatest possible chance of cure and with as few side effects as possible. Our starting point is that the patient retains control. We do this in a socially responsible way in collaboration with our partners in radiotherapy, with ground-breaking scientific research, training and education. Within MAASTRO, the research line of Knowledge EngiNoring and Clinical Data Science performs research with the aim to provide decision support systems for individualized radiotherapy. We have 3 general research themes. Build global data sharing infrastructures Learn cancer outcome prediction models from this data Apply outcome prediction models to improve lives of cancer patients To this end, we are pioNors in Personal Health Train distributed learning and clinical decision support systems for shared decision making.

www.maastro.nl
Mr. Virender Sharma Director Ernst & Young

At EY, our purpose is Building a better working world. The insights and quality services we provide help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities. Through our four integrated service lines _ Assurance, Advisory, Tax and Transaction Advisory Services _ and our deep sector knowledge, we help our clients to capitalize on new opportunities and assess and manage risk to deliver responsible growth. Our high-performing, multidisciplinary teams help them fulfill regulatory requirements, keep investors informed and meet stakeholder Nods. As industries converge, they create new value and opportunities for business. EY helps organizations identify and capitalize on these new opportunities. From mobility to health care to future cities, traditional industry boundaries are being disrupted, as sectors converge to adapt to technological and societal changes. Navigating this fast-changing environment requires agility and fresh thinking. As we reinvent how we work, live and play, EY is helping clients embrace industry disruption as an opportunity.

www.ey.com
Mr. Erwin Sieders Partner Ernst & Young

At EY, our purpose is Building a better working world. The insights and quality services we provide help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities. In a world that_s changing faster than ever, our purpose acts as our _North Star_ guiding our more than 260,000 people _ providing the context and meaning for the work we do every day. We help digital pioNors fight data piracy; guide governments through cash-flow crises; unlock new medical treatments with data analytics; and pursue high quality audits to build trust in financial markets and business. In other words, working with entrepreneurs, companies, and entire countries to solve their most pressing challenges. Through our four integrated service lines _ Assurance, Advisory, Tax and Transaction Advisory Services _ and our deep sector knowledge, we help our clients to capitalize on new opportunities and assess and manage risk to deliver responsible growth. Our high-performing, multidisciplinary teams help them fulfill regulatory requirements, keep investors informed and meet stakeholder Nods. We believe a better working world is one where economic growth is sustainable and inclusive. We work continuously to improve the quality of all of our services, investing in our people and innovation. And we_re proud to work with others _ from our clients to wider stakeholders _ to use our knowledge, skills and experience to help fulfill our purpose and create positive change.

www.ey.com
Mr. Daniel Mazon CEO Philips India Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people_s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries.

philips.com
Mr. Bartelt de Jongh medical microbiologist PUM Netherlands senior experts

The Netherlands is renowned for its restricted antimicrobial consumption, leading to the lowest antibiotic use and resistance rates in the world, while retaining high health outcomes. In LMICs, where the burden of antimicrobial resistance (AMR) is high, there is a demand for proven expertise (like the Dutch) to implement effective strategies. Senior medical specialists (clinical microbiologists, infectious disease consultants, pharmacists, infection control specialists and veterinarians) who have retired are a suitable workforce to support capacity strengthening activities on AMR in LMIC settings.

Registration Is Closed Now